Loading...
OTCM
CYAN
Market cap3mUSD
Dec 05, Last price  
0.47USD
1D
30.56%
1Q
56.67%
Jan 2017
-89.07%
Name

Cyanotech Corp

Chart & Performance

D1W1MN
OTCM:CYAN chart
P/E
P/S
0.14
EPS
Div Yield, %
Shrs. gr., 5y
3.48%
Rev. gr., 5y
-5.36%
Revenues
24m
+4.96%
11,131,0009,683,00011,364,00013,950,00015,742,00016,827,00024,631,00027,581,00028,905,00033,809,00031,840,00032,042,00034,115,00030,202,00031,899,00032,345,00035,968,00023,178,00023,071,00024,215,000
Net income
-3m
L-39.19%
-268,000-7,425,000-1,139,0001,142,0001,391,0001,730,0003,632,0004,209,000-195,000-24,000-4,395,000-1,215,0001,025,000-3,596,000387,000920,0002,154,000-3,440,000-5,267,000-3,203,000
CFO
-1m
L+162.20%
179,000-459,000-782,000908,0001,219,0001,747,0005,082,0001,897,0002,149,0001,239,000745,0001,220,0001,490,000-847,0001,243,0002,400,0002,379,000-2,100,000-455,000-1,193,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Cyanotech Corporation engages in the cultivation, production, and sale of natural products derived from microalgae worldwide. The company's products include BioAstin Hawaiian Astaxanthin, a dietary antioxidant to enhance skin, and to support eye, joint and immune health, as well as used as a human dietary supplement and dietary ingredient; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement, which is used for extra energy, strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids. It also provides contract extraction services. The company sells its products through distributors, retailers, and online channels; direct to consumers; and in bulk form to manufacturers, formulators, and distributors in the health foods, nutraceuticals, and dietary supplement markets. Cyanotech Corporation was incorporated in 1983 and is headquartered in Kailua-Kona, Hawaii.
IPO date
May 21, 1999
Employees
86
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT